H-2 restriction of adoptive immunotherapy of advanced tumors

Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.

Nature communications·2018

Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

Leukemia & lymphoma·2016

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

Leukemia & lymphoma·2016

Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

Gene therapy·2011

Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C.

Journal of viral hepatitis·2006

Development of a novel strategy for engineering high-affinity proteins by yeast display.

Protein engineering, design & selection : PEDS·2006

A gavage-fomite based method to generate mouse models with natural microbiota.

Journal of immunology (Baltimore, Md. : 1950)·2026

Exacerbation of inflammatory bone loss in TET2-driven clonal hematopoiesis.

Journal of immunology (Baltimore, Md. : 1950)·2026

Immunopeptidomics-driven MHC class II peptide-binding motif discovery for 2 common canine DR alleles.

Journal of immunology (Baltimore, Md. : 1950)·2026

Leishmania inhibits NLRP3 expression through IL-33/ST2 signaling driven SOCS1-mediated p65 degradation.

Journal of immunology (Baltimore, Md. : 1950)·2026

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

Journal of immunology (Baltimore, Md. : 1950)·2026

Arid2 regulates peripheral B cell maturation and germinal-center responses in vivo.

Journal of immunology (Baltimore, Md. : 1950)·2026

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Frontiers in medicine·2026

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

BMC gastroenterology·2026

Neoantigen cancer vaccines for gastrointestinal tumors: opportunities and challenges.

MedScience·2026

Related Experiment Videos

H-2 restriction of adoptive immunotherapy of advanced tumors

Related Concept Videos

Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.

Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C.

Development of a novel strategy for engineering high-affinity proteins by yeast display.

A gavage-fomite based method to generate mouse models with natural microbiota.

Exacerbation of inflammatory bone loss in TET2-driven clonal hematopoiesis.

Immunopeptidomics-driven MHC class II peptide-binding motif discovery for 2 common canine DR alleles.

Leishmania inhibits NLRP3 expression through IL-33/ST2 signaling driven SOCS1-mediated p65 degradation.

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

Arid2 regulates peripheral B cell maturation and germinal-center responses in vivo.

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

Neoantigen cancer vaccines for gastrointestinal tumors: opportunities and challenges.

Related Experiment Videos

H-2 restriction of adoptive immunotherapy of advanced tumors

Related Concept Videos

Related Articles